Rhabdomyosarcoma
MONDO:0005212A rare aggressive malignant mesenchymal neoplasm arising from skeletal muscle. It usually occurs in children and young adults. Only a small percentage of tumors arise in the skeletal muscle of the extremities. The majority arise in other anatomical sites.
Also known as: rhabdomyosarcoma, rhabdomyosarcoma (disease), rhabdomyosarcoma, malignant
2917 clinical trials for this condition and its sub-types, 100 tagged with Rhabdomyosarcoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Rhabdomyosarcoma
-
Alveolar rhabdomyosarcoma 9 trials
-
Pleomorphic rhabdomyosarcoma 7 trials
2 sub-types
- Adult pleomorphic rhabdomyosarcoma 0 trials
- Childhood pleomorphic rhabdomyosarcoma 0 trials
-
Embryonal rhabdomyosarcoma 4 trials
5 sub-types
- Botryoid rhabdomyosarcoma 2 trials Sub-types →
- Embryonal extrahepatic bile duct rhabdomyosarcoma 0 trials
- Orbit embryonal rhabdomyosarcoma 0 trials
- Parameningeal embryonal rhabdomyosarcoma 0 trials
- Prostate embryonal rhabdomyosarcoma 0 trials
-
Spindle cell rhabdomyosarcoma 3 trials
-
Testis rhabdomyosarcoma 1 trial
-
Breast rhabdomyosarcoma 0 trials
-
Gallbladder rhabdomyosarcoma 0 trials
-
Liver rhabdomyosarcoma 0 trials
1 sub-type
-
Mediastinum rhabdomyosarcoma 0 trials
-
Oral rhabdomyosarcoma 0 trials
-
Orbit rhabdomyosarcoma 0 trials
2 sub-types
- Orbit alveolar rhabdomyosarcoma 0 trials
- Orbit embryonal rhabdomyosarcoma 0 trials
-
Ovary rhabdomyosarcoma 0 trials
-
Prostate rhabdomyosarcoma 0 trials
1 sub-type
- Prostate embryonal rhabdomyosarcoma 0 trials
-
Rectum rhabdomyosarcoma 0 trials
1 sub-type
- Anus rhabdomyosarcoma 0 trials
-
Rhabdomyosarcoma of the cervix uteri 0 trials
-
Rhabdomyosarcoma, embryonal, 2 0 trials
-
Uterine corpus rhabdomyosarcoma 0 trials
-
Vaginal rhabdomyosarcoma 0 trials
1 sub-type
Most studied deeper sub-types
-
New combo therapy shows promise for kids with tough cancers
Disease control Stopped earlyThis study tested a combination of an immunotherapy drug (nivolumab) and low-dose chemotherapy in children and teenagers whose solid tumors had not responded to standard treatments. The goal was to see if the combination was safe and could help control the cancer. The trial was s…
Phase 1/2 • Sponsor: Centre Oscar Lambret • Aim: Disease control
Last updated Sep 19, 2026 00:00 UTC
-
Cancer drug combo trial for kids halted early
Disease control Stopped earlyThis early-stage study tested a combination of two drugs, niraparib and dostarlimab, in children and teens (ages 6 months to 17 years) with solid tumors that had come back or were not responding to treatment. The goal was to find a safe dose and see if the drugs could shrink tumo…
Phase 1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New drug cocktail shows promise for tough childhood cancers
Disease control Stopped earlyThis early-phase trial tested a combination of three drugs—ribociclib, topotecan, and temozolomide—in children with relapsed or refractory neuroblastoma and other solid tumors. The goal was to find a safe dose and see if the combination could shrink tumors. Only 12 children took …
Phase 1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC